M. Färnegårdh

发表

Structure and function of the radical enzyme ribonucleotide reductase.

U. Uhlin, H. Eklund, P. Nordlund, 2001, Progress in biophysics and molecular biology.

Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.

David C. Wood, K. Fennell, R. Kurumbail, 2018, Journal of medicinal chemistry.

The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain

Jonathan Greer, J. Greer, J. Gustafsson, 2003, Journal of Biological Chemistry.

The Orphan Nuclear Receptor SHP Utilizes Conserved LXXLL-Related Motifs for Interactions with Ligand-Activated Estrogen Receptors

J. Thomsen, E. Treuter, Eckardt Treuter, 2000, Molecular and Cellular Biology.

The Three-dimensional Structure of the Liver X Receptor β Reveals a Flexible Ligand-binding Pocket That Can Accommodate Fundamentally Different Ligands*

Sherry Sun, Anna Wilhelmsson, J. Gustafsson, 2003, Journal of Biological Chemistry.

Structure of the large subunit of class Ib ribonucleotide reductase from Salmonella typhimurium and its complexes with allosteric effectors.

U. Uhlin, H. Eklund, M. Färnegårdh, 2003, Journal of molecular biology.

Convergence of lipid homeostasis through liver X and thyroid hormone receptors

J. Gustafsson, A. Berkenstam, Jan-Åke Gustafsson, 2004, Mechanisms of Ageing and Development.

The first holocomplex structure of ribonucleotide reductase gives new insight into its mechanism of action.

Malin Uppsten, U. Uhlin, Mathias Färnegårdh, 2006, Journal of molecular biology.

A rapid intracellular enrichment of alkylating payload is essential for melphalan flufenamide potency and mechanism of action.

K. Ács, K. Fasth, Katarina Färnegårdh, 2023, Biochemical and biophysical research communications.

The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain RU-486 INDUCES A TRANSCONFORMATION THAT LEADS TO ACTIVE ANTAGONISM*

Jie Yang, J. Greer, S. Muchmore, 2003 .

Expression and preliminary crystallographic studies of R1E, the large subunit of ribonucleotide reductase from Salmonella typhimurium.

U. Uhlin, S. Ramaswamy, A. Jordan, 2003, Acta crystallographica. Section D, Biological crystallography.

Thyroid hormone antagonists: potential medical applications and structure activity relationships.

P. Ladenson, G. Grover, J. Malm, 2009, Current medicinal chemistry.

Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes.

K. Koehler, L. Hagberg, C. Jakob, 2004, Journal of medicinal chemistry.